H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Vertical genotype 1 HCV infection treated successfully in the second year of life: A case report

Małgorzata Pawłowska, Waldemar Halota, Ewa Smukalska

Med Sci Monit 2012; 18(12): CS113-116

DOI: 10.12659/MSM.883620

Published: 2012-12-01


Background:    Perinatal HCV transmission appears to be an important cause of HCV in children. Treatment of chronic hepatitis C in young children is controversial because of spontaneous HCV clearance and possible adverse events.
    Case Report:    Vertical HCV genotype 1 infection was diagnosed in a 3-month-old infant. In the subsequent clinical examination we still observed hepatomegaly, fluctuations of ALT, AST and GGT activity, with the highest values 2206 U/L, 1319 U/L, and 297 U/L, respectively. In qPCR, HCV RNA was >700.000 IU/ml. In the 42nd week of observation, liver biopsy was performed with Grade 1 grading and Grade 1 staging. At age 12 months, interferon-alpha2b (1.5 MU 3 times a week) and ribavirin (2×80 mg daily) were administered for 48 weeks. At the beginning of the treatment we observed fever after IFN injection. In the 12th week of therapy, HCV RNA disappeared followed by SVR, and it was sustained for 6 years. To our knowledge, this is the first report of a pediatric (1-year-old) patient treated with combined IFN alpha-2b and ribavirin therapy.
    Conclusions:    This case report confirms the possibility of successful anti-HCV treatment in a young child, with 6-year sustained virological response without significant adverse events.

Keywords: Infectious Disease Transmission, Vertical, Infant, Humans, Hepatitis C, Chronic - virology, Hepacivirus - genetics, Genotype, Follow-Up Studies, Child, Antiviral Agents - therapeutic use, Male, Treatment Outcome, Viral Load - drug effects



Back